Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 7/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | CDK2 | P24941 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 6/20 | 0.35 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.35 |
| ▸ | WDR5 | P61964 | 3/20 | 0.34 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6696733 | 0.93 | MMP13 (0.49) | MMP13TRPA1CDK2GSK3BEPHX2 | |
| SCHEMBL6698886 | 0.92 | MMP13 (0.51) | MMP13TRPA1CDK2GSK3BEPHX2 | |
| SCHEMBL6822709 | 0.86 | MMP13 (0.44) | MMP13TRPA1WDR5 | |
| SCHEMBL6696978 | 0.79 | PTGER4 (0.46) | MMP13EPHX2NR1H4 | |
| SCHEMBL6288755 | 0.77 | TP53 (0.45) | MMP13EPHX2NR1H4 | |
| SCHEMBL6698006 | 0.74 | MMP13 (0.49) | MMP13TRPA1CDK2GSK3BEPHX2 | |
| SCHEMBL6289016 | 0.71 | SCD (0.43) | MMP13 | |
| SCHEMBL6348866 | 0.70 | MMP13 (0.51) | MMP13TRPA1CDK2GSK3BEPHX2 | |
| SCHEMBL6288787 | 0.70 | PTGER4 (0.46) | MMP13EPHX2NR1H4 | |
| SCHEMBL6696562 | 0.69 | PTGER4 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004014916-A1 | PYRIMIDINE FUSED BICYCLIC METALLOPROTEINASE INHIBITORS | WARNER-LAMBERT COMPANY LLC (US) | 2004-02-19 | — | — | WO | claimed |